Literature DB >> 16077214

Pulmonary tuberculosis in two remand prisons (SIZOs) in St Petersburg, Russia.

T Lobacheva1, V Sazhin, E Vdovichenko, J Giesecke.   

Abstract

The tuberculosis (TB) situation in the Russian penitentiary system has received much attention. We performed a descriptive epidemiological study of TB in two St Petersburg remand prisons (SIZOs). The medical databases of the TB divisions in these prisons were searched for all diagnosed cases of TB from 1 January 2000 to 31 December 2002. The main diagnostic method was chest x ray. The total number of reported TB cases in these two remand prisons during this three-year period was 876. Out of these, 432 were diagnosed at entry to prison, and 444 developed the disease during incarceration, with the proportion diagnosed during incarceration increasing over time. The majority of cases were aged under 30 years. TB incidence in Russian remand prisons is still very high and needs to be monitored closely.

Entities:  

Mesh:

Year:  2005        PMID: 16077214

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  4 in total

1.  Risk factors for developing tuberculosis in remand prisons in St. Petersburg, Russia - a case-control study.

Authors:  Tatiana Lobacheva; Tommi Asikainen; Johan Giesecke
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

2.  Addressing institutional amplifiers in the dynamics and control of tuberculosis epidemics.

Authors:  Sanjay Basu; David Stuckler; Martin McKee
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

Review 3.  Tuberculosis incidence in prisons: a systematic review.

Authors:  Iacopo Baussano; Brian G Williams; Paul Nunn; Marta Beggiato; Ugo Fedeli; Fabio Scano
Journal:  PLoS Med       Date:  2010-12-21       Impact factor: 11.069

Review 4.  Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic.

Authors:  F Biadglegne; A C Rodloff; U Sack
Journal:  Epidemiol Infect       Date:  2014-11-07       Impact factor: 4.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.